Abstract:Dogs share physiological similarities with humans, positioning them as valuable models for studying the efficacy and safety of drugs and their underlying mechanisms of action. The JAK-STAT pathway, a highly conserved signaling pathway across species, including humans and dogs, presents an opportunity to investigate the therapeutic potential of cytokines that utilize this pathway. In this study, we aimed to evaluate the functional activity of three canine cytokines on canine cells. To assess stimulation of the JAK/STAT pathway, we used a flow cytometry assay that measures phospho-STAT in activated canine or human lymphocytes in whole blood specimens. Testing of commercially available human and canine IL-6 proteins revealed that canine lymphocytes respond poorly to most canine IL-6 products, whereas all recombinant human IL-6 products stimulated STAT phosphorylation in canine lymphocytes, despite sharing low sequence similarity with canine IL-6. In human T cells, both canine IL-6 and human IL-6 stimulated STAT phosphorylation, demonstrating biological activity from the canine IL-6 products. Several JAK inhibitors inhibited cytokine-induced STAT phosphorylation in both canine and human CD4 T-cells, consistent with JAK inhibition, but targeting the IL-6 receptor with tocilizumab only blocked IL-6-induced STAT phosphorylation in human but not canine CD4 T-cells in whole blood. These findings demonstrate the potential of our assay system to assess cross-species cytokine reactivity, determine if JAK/STAT inhibitors used clinically might be useful in treating inflammatory conditions in dogs, and identify novel canine-specific inhibitors. Additionally, we explored the induction of IL-8 by human and canine IL-1 alpha in IL-1 alpha sensitive human cells. Human IL-1 alpha failed to stimulate a canine IL-1 alpha sensitive cell line, suggesting species-specific differences in IL-1 alpha activity. Furthermore, we discovered that canine IL-7 and human IL-7 are species-specific. In summary, this proof-of-concept study highlights the capability to assess the activation of STATs and pathway inhibition by JAK inhibitors in canine whole blood using flow cytometry. We confirmed that human IL-6 stimulates JAK/STAT signaling in canine CD4 T-cells. Our results also revealed significant differences in species cross-reactivity of human IL-6, IL-7, and IL-1 alpha, underscoring the importance of species-specific investigations. Leveraging the similarities and differences between canine and human cytokines targeting the JAK-STAT pathway can enhance drug development efforts and contribute to the advancement of safer and more effective therapies for both humans and pet dogs with similar diseases. This study was funded by NCI Contract No. 75N91019D00024. Citation Format: King Leung Fung, Melissa L. Breiner, James B. Mitchell, Ralph E. Parchment. Conservation of JAK-STAT signaling in canine lymphocytes responding to human IL-6, IL-7, and IL-1 alpha [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 2837.

Interleukin-1β promotes interleulin-6 expression via ERK1/2 signaling pathway in canine dermal fibroblasts

Activation of MEK/ERK pathways through NF-κB activation is involved in interleukin-1β-induced cyclooxygenease-2 expression in canine dermal fibroblasts

Tnf-Alpha Induction Of Il-6 In Alveolar Type Ii Epithelial Cells: Contributions Of Jnk/C-Jun/Ap-1 Element, C/Ebp Delta/C/Ebp Binding Site And Ikk/Nf-Kappa B P65/Kappa B Site

THE MITOGEN-ACTIVATED PROTEIN KINASE p38 IS NECESSARY FOR INTERLEUKIN-1β-INDUCED MONOCYTE CHEMOATTRACTANT PROTEIN 1 EXPRESSION BY HUMAN MESANGIAL CELLS

Abstract 2837: Conservation of JAK-STAT signaling in canine lymphocytes responding to human IL-6, IL-7, and IL-1 alpha

Interleukin 1β regulates the expression of peroxisome proliferator-activated receptor γ and its coregulators in renal tubular cells

Interleukin-1 Beta-Induced Transdifferentiation Of Renal Proximal Tubular Cells Is Mediated By Activation Of Jnk And P38 Mapk

Interleukin-6 as a Multifunctional Regulator: Inflammation, Immune Response, and Fibrosis

IL-1β-activated PI3K/AKT and MEK/ERK pathways coordinately promote induction of partial epithelial-mesenchymal transition

Interleukin-6 Induces Epithelial-Mesenchymal Transition in Human Intrahepatic Biliary Epithelial Cells

Interleukin (IL)-6 modulates transforming growth factor-β receptor I and II (TGF-βRI and II) function in epidermal keratinocytes

Pro-inflammatory cytokine expression and the STAT1/3 pathway in canine chronic enteropathy and intestinal T-cell lymphoma

IL-1β and TNF-α Regulate IL-6-type Cytokines in Gingival Fibroblasts

IL-1β Promotes the Secretion of Angiogenic and Inflammatory Factors in Human Dermal Fibroblast

Effects and Relationship of ERK1 and ERK2 in Interleukin-1Β-induced Alterations in MMP3, MMP13, Type II Collagen and Aggrecan Expression in Human Chondrocytes.

Role of Interleukin-1α and Interleukin-6 in the Interaction Between Keratinocytes and Dermal Fibroblasts

Proinflammatory cytokines suppress stemness-related properties and expression of tight junction in canine intestinal organoids

Role of Extracellular Signal-Regulated Kinase in Regulating Expression of Interleukin 13 in Lymphocytes from an Asthmatic Rat Model

Interleukin‐25 regulates matrix metalloproteinase‐2 and ‐9 expression in periodontal fibroblast cells through ERK and P38MAPK pathways

Analysis of Isoform Specific ERK Signaling on the Effects of Interleukin-1Β on COX-2 Expression and PGE2 Production in Human Chondrocytes.

[Il-1Beta Stimulates Alpha-Smooth Muscle Actin Expression Through JNK/p38 Signal Pathway in Cultured Rat Mesangial Cells].